首页> 外文会议>SPIE Conference on Biomedical applications in molecular, structural, and functional imaging >Assessment of contrast flow modification in aneurysms treated withclosed-cell self-deploying asymmetric vascular stents (SAVS)
【24h】

Assessment of contrast flow modification in aneurysms treated withclosed-cell self-deploying asymmetric vascular stents (SAVS)

机译:用闭合细胞自部署不对称血管支架进行动脉瘤治疗的动脉瘤中对比度流动修饰评估(SAVS)

获取原文

摘要

The Asymmetric Vascular Stent (AVS) for intracranial aneurysm (IA) treatment is an experimental device, specially designed for intra-aneurysmal blood flow diversion and thrombosis promotion. The stent has a low-porous patch to cover only the aneurysm neck while the rest of the stent is very porous to avoid blockage of adjacent branches. The latest AVS design is similar to state-of-art, closed-cell, self-expanding, neurovascular stent. The stents were used to treat sixteen rabbit-elastase aneurysm models. The treatment effect was analyzed using normalized-time-density-curves (NTDC) measured by pixel-value integration over a region-of-interest containing the aneurysm. Normalization constant was the total bolus injection determined angiographically. Based on NTDC measurement, five quantities were derived to describe the contrast flow. Two are related to the amount of contrast entering the aneurysm: NTDC peak and NTDC input slope. The other three are related to contrast presence in the aneurysmal dome: time-to-peak (TTP), wash-out-time (WOT) and mean-transit-time (MTT). Flow modification descriptions using the contrast related quantities were expressed as a pre-/post-stented NTDC parameter ratio, while the time related quantities were expressed as a post-/pre-stented ratio, so that ratios smaller than one indicate a desired effect. Thirteen aneurysms were treated successfully and achieved significant aneurysm occlusion. For these cases, the resulting average parameters were: peak-ratio=0.17+0.21; input-slope-ratio=0.19±0.24, TTP-ratio=0.17+0.21, WOT-ratio=0.58±0.73 and MTT-ratio=0.65±0.97). All the quantities revealed decreased aneurysmal flow due to blood flow diversion using the new self-expanding asymmetrical vascular stent (SAVS). Treatment outcome results and angiographic analysis indicate that the new self-deploying stent design has great potential for clinical implementation.
机译:用于颅内动脉瘤(IA)处理的不对称血管支架(AVS)是一种实验装置,专为动脉内血流导流和血栓形成促进而设计。支架具有低多孔贴片,仅覆盖动脉瘤颈部,而其余支架是非常多孔的,以避免堵塞相邻的分支。最新的AVS设计类似于最先进的,闭合细胞,自我扩张的神经血管支架。该支架用于治疗16兔 - 弹性蛋白酶动脉瘤模型。使用归一化 - 时间密度曲线(NTDC)分析治疗效果,通过像素值集成在含有动脉瘤的感兴趣区域上测量。归一化常数是血管造影的总推注注射。基于NTDC测量,得出了五种数量以描述对比度流动。两个与进入动脉瘤的对比度有关:NTDC峰和NTDC输入斜率。其他三种与动脉瘤圆顶中的对比度有关:时间 - 峰值(TTP),洗涤 - 输出时间(WOT)和平均转运时间(MTT)。使用对比度相关量的流动修饰描述表达为预/后止动的NTDC参数比,而时间与止动的数量表示为/预支架的比例,从而小于一个比例的比率表示所需的效果。 13个动脉瘤被成功治疗并实现了显着的动脉瘤闭塞。对于这些情况,所得到的平均参数为:峰值= 0.17 + 0.21;输入边坡比= 0.19±0.24,TTP比率= 0.17 + 0.21,WOT比率= 0.58±0.73和MTT比率= 0.65±0.97)。所有数量都显示出由于血流转移而导致的动脉瘤流量降低,使用新的自扩张不对称血管支架(SEVS)。治疗结果结果和血管造影分析表明,新的自部署支架设计具有巨大的临床实施潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号